Take Up Global Pharmacovigilance Market Opportunities with Clear Industry Data – Includes Pharmacovigilance Market Research

The Business Research Company’s report goes into great detail on the pharmacovigilance market size and growth, pharmacovigilance market regional analysis, pharmacovigilance market competitive landscape, and other critical information needed to excel in the pharmacovigilance industry.


Major players in the pharmacovigilance market include Accenture, Cognizant, Labcorp Drug Development, IQVIA, IQVIA, Parexel International Corporation, BioClinica Inc., Clinquest Inc., ITClinical, TAKE Solutions Limited, United BioSource LLC, Wipro Limited, Bristol-Myers Squibb Company, Linical Americas, iMEDGlobal, Boehringer Ingelheim International GmbH, Novartis AG, Ecron Acunova Limited, and Sanofi.


TBRC’s comprehensive market report based on extensive research will assist you in seamlessly devising your approaches in order to match key market player strategies.


The global pharmacovigilance market is expected to grow from $5.71 billion in 2021 to $6.64 billion in 2022 at a compound annual growth rate (CAGR) of 16.2%. The global pharmacovigilance market is expected to reach $10.57 billion in 2026 at a CAGR of 12.3%.


North America was the largest region in the pharmacovigilance market in 2021.


The pharmacovigilance market consists of sales of pharmacovigilance services by entities (organizations, sole traders, and partnerships) that collect, assess, and distribute drug safety and efficiency data. Pharmacovigilance is the science and practice of monitoring approved pharmaceuticals and experimental products prior to their approval for use in order to discover, evaluate, assess, and avoid adverse drug and vaccination effects and problems.


The growing incidences of adverse drug reactions are expected to propel the growth of the pharmacovigilance market going forward.


Request a Sample of the Global Pharmacovigilance Market Report


Pharmacovigilance Market
Pharmacovigilance Market


Technological advancements have emerged as a key trend gaining popularity in the pharmacovigilance market. Many companies operating in the pharmacovigilance sector are adopting advanced technological solutions such as Artificial intelligence (AI) to reduce cycle time, enriched quality and accuracy, scalable and futuristic solutions, improved productivity, and better compliance.


TBRC’s Global Pharmacovigilance Market Report Is Segmented:
By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining

By Service Provider: In-House, Contract Outsourcing

By Process Flow: Case Data Management, Signal Detection, Risk Management System

By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV

By End User: Hospitals, Pharmaceutical Companies, Other End Users

By Geography: North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.


The Pharmacovigilance Global Market Report 2022 is one of a series of new reports from The Business Research Company that provides an overview of the pharmacovigilance market globally and regionally, analyzes and forecasts market size, share, pharmacovigilance market players, pharmacovigilance market segments, leading competitor revenues, profiles and market shares.


Here Is A List Of Similar Reports From The Business Research Company:

Pharma Microbiology Testing Kits Global Market Report 2022

Pharmaceutical API Manufacturing Global Market Report 2022

Pharmaceutical Excipients Global Market Report 2022


Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.


Read more about us at


Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293


Follow us on LinkedIn:

Follow us on Twitter:

Check out our Global Market Model:


Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *